Monday, May 23, 2022 6:51:51 AM
Gilead is at it again, Meryl Nass, M.D. likens FDA collaboration to approve dangerous drug Remdesivir for infants as young as 28 days old to Tamiflu in which Gilead ‘massaged’ data in order to get FDA approval.
“Approval was based on a single trial of 53 children conducted by Gilead”, 3 of which died, she unpacks.
Nass asserts that Remdesivir in general has been used improperly over the last 2 years during a period when the live virus is no longer present in the body.
https://rumble.com/v134ift-infants-to-be-guinea-pigs-as-remdesivir-dangerously-approved-by-fda-without.html
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM